Shopping Cart
- Remove All
Your shopping cart is currently empty
Rhamnazin (3',7-Dimethylquercetin) is an orally active VEGFR2 signaling inhibitor with anti-angiogenesis, anti-tumor, antioxidant, and anti-inflammatory activities. It inhibits VEGFR2 kinase and is used for leukemia research.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $279 | In Stock | |
| 5 mg | $838 | In Stock | |
| 10 mg | $1,130 | In Stock | |
| 25 mg | $1,680 | In Stock | |
| 1 mL x 10 mM (in DMSO) | $849 | In Stock |
| Description | Rhamnazin (3',7-Dimethylquercetin) is an orally active VEGFR2 signaling inhibitor with anti-angiogenesis, anti-tumor, antioxidant, and anti-inflammatory activities. It inhibits VEGFR2 kinase and is used for leukemia research. |
| Targets&IC50 | VEGFR2:4.68 μM |
| In vitro | Rhamnazin (5, 10, and 15 µM, 24h) reduces the proliferation and invasion of hepatocellular carcinoma (HCC) cells. [2] Rhamnazin directly inhibited VEGFR2 kinase activity in a dose-dependent manner with an IC50 of 4.68 μM. [3] |
| In vivo | Treatment with Rhamnazin (10-30 mg/kg) significantly improved experimental brain injury in rats, with results showing significant reduction of edema and improved grip strength. [1] Rhamnazin (200 mg/kg/ day orally) significantly inhibited the growth of human tumor xenografts and reduced the microvascular density (MVD) of tumor sections. [3] |
| Synonyms | 3',7-Dimethylquercetin |
| Molecular Weight | 330.29 |
| Formula | C17H14O7 |
| Cas No. | 552-54-5 |
| Smiles | O=C1C(O)=C(OC2=CC(OC)=CC(O)=C12)C=3C=CC(O)=C(OC)C3 |
| Relative Density. | 1.507 g/cm3 (Predicted) |
| Storage | keep away from direct sunlight,keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.